Gilead director Bluestone exercises options, sells 5,000 shares
Rhea-AI Filing Summary
Gilead Sciences director Jeffrey Bluestone exercised non-qualified stock options for 5,000 shares of common stock at $67.4500 per share on January 20, 2026, then sold 5,000 shares at $123.5000 per share the same day under a Rule 10b5-1 trading plan adopted on February 13, 2025. After these transactions, he holds 8,920 shares of Gilead common stock directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and Sale: 5,000 shares ($280K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Bluestone Jeffrey
Role
Director
Sold
5,000 shs ($618K)
Approx. gross sale proceeds
$618K
Approx. exercise cost
$337K
Approx. pre-tax spread
$280K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-qualified Stock Option (Right to Buy) | 5,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 5,000 | $67.45 | $337K |
| Sale | Common Stock | 5,000 | $123.50 | $618K |
Holdings After Transaction:
Non-qualified Stock Option (Right to Buy) — 4,665 contracts (Direct);
Common Stock — 8,920 shares (Direct)
Footnotes (2)
- F1. The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.
- F2. 25% of the shares subject to the option vest on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting.
Key Figures
Options exercised: 5000.0000 shares
Option exercise price: $67.4500 per share
Shares sold: 5000.0000 shares
+3 more
6 metrics
Options exercised
5000.0000 shares
Non-qualified Stock Option exercised on 2026-01-20
Option exercise price
$67.4500 per share
Exercise price for Non-qualified Stock Option
Shares sold
5000.0000 shares
Common Stock sale on 2026-01-20
Sale price
$123.5000 per share
Per-share price for Common Stock sale
Post-transaction holdings
8,920 shares
Common Stock held directly after transactions
Option expiration date
2031-05-12
Expiration of Non-qualified Stock Option
Key Terms
Non-qualified Stock Option (Right to Buy), Rule 10b5-1 trading plan, Exercise or conversion of derivative security
3 terms
Non-qualified Stock Option (Right to Buy) financial
"security_title: Non-qualified Stock Option (Right to Buy)"
Rule 10b5-1 trading plan regulatory
"transactions reported ... pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transactions did GILD director Jeffrey Bluestone report on January 20, 2026?
Jeffrey Bluestone reported exercising options for 5,000 shares of Gilead common stock and then selling 5,000 shares on January 20, 2026. The exercise converted a non-qualified stock option into common stock, followed by a same-day sale.
What options did Jeffrey Bluestone exercise in this GILD Form 4 filing?
He exercised a Non-qualified Stock Option for 5,000 shares of Gilead common stock at an exercise price of $67.4500 per share. The option is reported with an expiration date of May 12, 2031 and relates to common stock.
Were Jeffrey Bluestone’s GILD transactions made under a Rule 10b5-1 trading plan?
Yes. The filing states that all reported transactions were made pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025. Such pre-arranged plans allow insiders to sell shares according to preset instructions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
